Variants of ST8SIA1 are associated with risk of developing multiple sclerosis

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Husain, Seema ^a   Yildirim Toruner, Cagri ^a   Rubio, Justin P ^b   Field, Judith ^b   Schwalb, Marvin ^a   Cook, Stuart ^c   Devoto, Marcella ^d,e   Vitale, Emilia ^a,f  

^a UMDNJ New Jersey Medical School   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HLA DQ ANTIGEN; HLA DR ANTIGEN; ST8 ALPHA N ACETYLNEURAMINIDE ALPHA 2,8 SIALYLTRANSFERASE 1; ALPHA N ACETYLNEURAMINATE ALPHA 2,8 SIALYLTRANSFERASE; ALPHA-N-ACETYLNEURAMINATE ALPHA-2,8-SIALYLTRANSFERASE; SIALYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; AUSTRALIA; CHROMOSOME 12P; CLINICAL ARTICLE; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PATERNALISM; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

AUSTRALIA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SIALYLTRANSFERASES; VARIATION (GENETICS);

EID: 50349084027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002653     Document Type: Article

References (31)

1. Steinman L (1996) Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85: 299-302.
2. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23: 683-747.
3. De Stefano N, Narayanan S, Francis SJ, Smith S, Mortilla M, et al. (2002) Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol 59: 1565-1571.
4. Barnett MH, Sutton I (2006) The pathology of multiple sclerosis: a paradigm shift. Curr Opin Neurol 19: 242-247.
5. Bjartmar C, Wujek JR, Trapp BD (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206: 165-171.
6. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127.
7. De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, et al. (1998) Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121 (Pt 8): 1469-1477.
8. Hafler DA (2004) Multiple sclerosis. J Clin Invest 113: 788-794.
9. Compston A (1999) The genetic epidemiology of multiple sclerosis. Philos Trans R Soc Lond B Biol Sci 354: 1623-1634.
10. Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, et al. (1986) A population-based study of multiple sclerosis in twins. N Engl J Med 315: 1638-1642.
11. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851-862.
12. Nara K, Watanabe Y, Maruyama K, Kasahara K, Nagai Y, et al. (1994) Expression cloning of a CMP-NeuAc:NeuAc alpha 2-3Gal beta 1-4Glc beta 1-1'Cer alpha 2,8-sialyltransferase (GD3 synthase) from human melanoma cells. Proc Natl Acad Sci U S A 91: 7952-7956.
13. Matsuda Y, Nara K, Watanabe Y, Saito T, Sanai Y (1996) Chromosome mapping of the GD3 synthase gene (SIAT8) in human and mouse. Genomics 32: 137-139.
14. Bieberich E, MacKinnon S, Silva J, Li DD, Tencomnao T, et al. (2002) Regulation of ganglioside biosynthesis by enzyme complex formation of glycosyltransferases. Biochemistry 41: 11479-11487.
15. Kolter T, Proia RL, Sandhoff K (2002) Combinatorial ganglioside biosynthesis. J Biol Chem 277: 25859-25862.
16. Tettamanti G (2004) Ganglioside/glycosphingolipid turnover: new concepts. Glycoconj J 20: 301-317.
17. Vitale E, Cook S, Sun R, Specchia C, Subramanian K, et al. (2002) Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12. Hum Mol Genet 11: 295-300.
18. Marrosu MG, Sardu C, Cocco E, Costa G, Murru MR, et al. (2004) Bias in parental transmission of the HLA-DR3 allele in Sardinian multiple sclerosis. Neurology 63: 1084-1086.
19. Ebers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, et al. (2004) Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 363: 1773-1774.
20. Luedi PP, Dietrich FS, Weidman JR, Bosko JM, Jirtle RL, et al. (2007) Computational and experimental identification of novel human imprinted genes. Genome Res 17: 1723-1730.
21. Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, et al. (1998) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet 7: 1229-1234.
22. Lundmark F, Duvefelt K, Hillert J (2007) Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosis. J Neuroimmunol 192: 171-173.
23. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, et al. (2007) Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 39: 1108-1113.
24. Kantarci OH, Barcellos LF, Atkinson EJ, Ramsay PP, Lincoln R, et al. (2006) Men transmit MS more often to their children vs women: the Carter effect. Neurology 67: 305-310.
25. Herrera BM, Ramagopalan SV, Orton S, Chao MJ, Yee IM, et al. (2007) Parental transmission of MS in a population-based Canadian cohort. Neurology 69: 1208-1212.
26. Ramagopalan SV, Herrera BM, Bell JT, Dyment DA, Debra GC, et al. (2007) Parental transmission of HLA-DRB1*15 in multiple sclerosis. Hum Genet.
27. Lassmann H (1998) Neuropathology in multiple sclerosis: new concepts. Mult Scler 4: 93-98.
28. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231.
29. Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, et al. (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal bonding, and CT. Neurology 38: 180-185.
30. Polman CH, Wolinsky JS, Reingold SC (2005) Multiple sclerosis diagnostic criteria: three years later. Mult Scler 11: 5-12.
31. Dudbridge F (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25: 115-121.